Novartis Raises Annual Sales Growth Forecast After Restructuring
Novartis AG raised its mid-term sales growth forecast as the Swiss drugmaker narrows its focus on innovative medicines
2023-11-28 15:46
Swiss Stocks Are Lagging Eurozone Peers By the Most Since 1999
Switzerland’s typically staid stock market is headed for its worst annual showing against euro zone peers since 1999,
2023-11-08 15:16
Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life
2023-10-04 16:18
European Stocks Edge Up as Investors Focus on Company Earnings
European stocks edged up on Tuesday as investor focus started to turn to company earnings from economic data
2023-07-18 17:17
Novartis Raises Outlook, Plans Buyback of Up to $15 Billion
Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in
2023-07-18 13:50
Novartis Sells Eye Drugs to Bausch for Up to $2.5 Billion
Novartis AG agreed to sell part of its portfolio of eye medicines to Bausch + Lomb Corp. in
2023-06-30 20:47
Carson Block’s Latest Short Bet Is Burned by Novartis M&A Deal
Carson Block’s Muddy Waters wager against a hedge-fund favorite, Chinook Therapeutics Inc., took a hit Monday after Novartis
2023-06-12 23:48
Credit Suisse's Exit From Stock Benchmark Shows Fading Heft of Swiss Financials
Credit Suisse Group AG’s imminent exit from the Swiss Market Index is symbolic of the decreasing importance of
2023-06-12 16:16
Novartis Agrees to Buy Chinook for Up to $3.5 Billion
Novartis AG agreed to buy Chinook Therapeutics Inc. for as much as $3.5 billion to add two promising
2023-06-12 13:49
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:15